Simple research view

TFX · Teleflex Incorporated

$132.00 -2.74% Sep 10 close

Detected setup Trend Only · Setup Score 57/100

Stand aside — setup invalidated

Setup score 57, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about TFX

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$TFX

Teleflex Incorporated

Teleflex Incorporated is a mid-cap Medical Specialties company in the Health Technology sector with a market cap of $6B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 3+

$132.00 latest close

Join to Watchlist $TFX Share card

Historical record

No active setup in the latest scan — this page shows the last detection Legend AI made for $TFX. Every level, score and criterion below is computed from the Sep 10 close session (1 session old), and may no longer hold.

Historical verdict · setup score 57/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 57, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

TFX-2.74%

Sector proxy · XLV-0.55%

Broad market · SPY-0.60%

Same completed session window ending 2026-09-10. TFX was -2.19 points vs XLV. -2.14 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-2.74% From the open-2.19% Range position25% GapNo gap

QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $132.00 -2.7% Sep 10 close

52W High $145.00 6.4% below high

Wks Since High 1w 4w today

Base Depth 4.5% 10.3% today

RS Rank 13 percentile of scan

SMA 50 $135.59

Avg Vol 549,118

Rel Vol (Sep 10) 1.39×

More stats

52W Low $100.18

Tight Wks 0

Base B3

SMA 200 $123.57

RS Line vs High -11.6%

RS Line Slope +0.9% ▲

Group Rank #25/58

ADR% 2.9%

ATR(14) $4.28 (3.2%)

Vol Pace (live) N/A

U/D Vol 0.94

A/D Days 14A / 12D

A/D Rating B

VDU Bars 0/10 d

Position in 52-week range 71stpercentile of the 52-week range

$100.18low

$145.00high

TFX Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for TFX.

Create Free Account

Technical Analysis Report Card

$TFX · $132.00 · as of 2026-09-10 · multi-factor read

/ 100

Technicals 40/100

Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating

Weekly ▬ Sideways / consolidating

Monthly ▬ Sideways / consolidating

Moving Averages

50-day$135.59 ↓

100-day$132.55 ↓

200-day$123.57 ↑

Bullish (50 > 200)

RSI (14)

Reading40.0 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateWeakening

Histogram-0.771

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width2% · 8.4%

Near the lower band — under pressure or oversold.

Volume · Buyer vs Seller

Up/Down vol0.94 · Neutral

Rel volume1.39×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $136.29swing level

R · $139.43swing level

R · $144.5852-week high

Price · $132.00now

S · $130.46swing level

S · $128.01swing level

S · $124.49swing level

Fibonacci · Uptrend swing

23.6%$135.11

38.2%$128.99

50.0%$124.04

61.8%$119.09

78.6%$112.05

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for TFX — plus the full 500+ symbol scanner and Ask-the-Legends chat.

Start your 7-day free trial →

Above 200-day MA50/200 bullishRS 22 (laggard)

Want this read in a legend's voice? Ask a Legend about TFX

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Watch

Minervini C

Trend-template read: 6/10 pass; wait for the soft misses to improve.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $135.72, MA150 $126.16, MA200 $123.43

1.2 150-day MA > 200-day MAMA150 $126.16 vs MA200 $123.43

Failing evidence

1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 22

2. Quarterly EPS growth ≥ 25%From SEPA scan

6/10 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

N: Near 52-week high or RS line new high6.4% below high | RS line new high: False

S: Base tightness (ATR% ≤ 4.5%)ATR% 3.03%

Failing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 22

C: Quarterly EPS acceleration ≥ 25%Data unavailable

2/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $135.72 vs MA200 $123.43

Failing evidence

Volume expansion above averageVolume ratio 0.90x

Relative strength ≥ 60RS 22

5/7 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$135.72

Distance from 52-week high6.4% below high

Failing evidence

Relative strengthRS 22

Volume vs average0.90x

3/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$135.72

Distance from 52-week high6.4% below high

Failing evidence

Relative strengthRS 22

Volume vs average0.90x

3/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$135.72

Distance from 52-week high6.4% below high

Failing evidence

Relative strengthRS 22

Volume vs average0.90x

3/6 checks

Method → Playbook → Ask →

Base & Breakout

Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +7 B

Minervini · Grade Card

Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met

C 2/7 criteria

Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ —

✗ Revenue growth ≥20% YoY +17%

✗ Gross margin ≥30% —

✗ ROE ≥17% —

✗ RS rating ≥80 (leadership) 22

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -9.0%

Method Playbook

Trade it like Livermore EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.

Pivot

Pro level

Published-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis (historical)

Trend Only

57 setup score

RS Score 22

Trend template 6/8

Why This Setup?

Trend Only · schematic

Gatekeeper 7/8 | Strong trend (7/8) | Stage 2

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met

A relative-strength leader — not met RS rank 13 — laggard
Risk is defined — not met No stop — undefined risk
Asymmetric reward — partly met No target set
Clear of earnings — partly met Report date unknown
Not chasing (in range) — partly met Pivot distance unknown
Volume confirms — partly met 1.4× average — light
In a confirmed uptrend — met Stage 2 · Trend template 6/8

Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $132.00 vs SMA150 $126.33 / SMA200 $123.57

SMA 150 above SMA 200 SMA150 $126.33 vs SMA200 $123.57

SMA 200 trending up Slope +2.09 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $135.59

Price above SMA 50 $132.00 vs SMA50 $135.59

30%+ above 52-week low +31.8% from $100.18

Within 25% of 52-week high -9.0% from $145.00

RS score above 70 RS 22

Fundamentals

52W Range

71%

Mkt Cap SEC

5.6B

Rev YoY

+17%

EPS TTM

$-20.25

Float

42M

Company

Company profile

Teleflex Incorporated

TFX · NYSE · Health Technology · Medical Specialties

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

7/8

W. RS

W. Support

$103.08

W. Resist

$145.00

Weekly Structure

Trend Neutral

Tight Weeks 0

Confirmation Neutral

Scan History

Sep 10

Trend Only ✓ Gate

Sep 09

Trend Only ✓ Gate

56 -2.7%

Sep 09

Trend Only ✓ Gate

56 -2.7%

Sep 09

Trend Only ✓ Gate

56 -2.7%

Sep 08

Wyckoff SOS ✓ Gate

63 -3.6%

Sep 08

Trend Only ✓ Gate

61 -3.6%

Get the full picture on TFX

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial